Search images on Google Product Monograph
Active Ingredients:
- trastuzumab, 150 MG/VIAL
DIN: 02518244
Dosage Form(s): POWDER FOR SOLUTION
Route(s) of Administration: INTRAVENOUS
Description: SINGLE-USE VIAL
Schedule: Prescription
Company: AMGEN CANADA INC
ATC:
- L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
- L01F - (ATC, WHO)
- L01FD - (ATC, WHO)
- L01FD01 - TRASTUZUMAB (WHO)